Latest filing published 05 Mar 2021 for OncoZenge AB (publ), €1,095.
Filing timeline
BuySaleInsider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Mark Beveridge: trading record in brief
This profile gathers the share dealings of Mark Beveridge in OncoZenge AB (publ). Altogether 3 filings, all relating to 2 March 2021.
Market trades split into 1 purchase (€1,095) and 2 sales (€2,736). Taken together, the sales exceed the purchases by €1,641. Unlike grants, an open-market purchase is paid for by the insider, at the market price.
The newest entry dates from 5 March 2021: an open-market purchase of €1,095, in OncoZenge AB (publ). Typically, a trade is published a median of 3 days after it takes place. The legal deadline for notifying a trade is three business days (MAR article 19). A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. This summary is built from Finansinspektionen disclosures alone and does not predict where the share price will go.
Companies and markets linked to Mark Beveridge
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 9,259 shares@ SEK 1.2040.0% of flowTeckningsrätt/UniträttISIN SE0015531223FI:csv-4067e190098200ad63f9
- 15,144 shares@ SEK 1.1060.0% of flowTeckningsrätt/UniträttISIN SE0015531223FI:csv-b42c5962a22961cd09e7
2 of 2 declarations